4.3.1 Sintesi e raccomandazioni - Biblioteca Medica

2. Feifer AH, Fleshner NE, Klotz L: Analytical accuracy and reliability of commonly used
nutritional supplements in prostate disease. J Urol. 2002 Jul; 168(1): 150-4; discussion
154.
3. McPartland JM, Pruitt PL. Benign prostatic hyperplasia treated with saw palmetto: a
literature search and an experimental case study: J Am Osteopath Assoc. 2000
Feb;100(2):89-96.
4. Wilt T, Ishani A, Mac Donald R.: Serenoa repens for benign prostatic hyperplasia. Cochrane
Database Syst Rev. 2002; (3): CD001423.
5. Boyle P, Robertson C, Lowe F, Roehrborn C.: Meta-analysis of clinical trials of permixon
in the treatment of symptomatic benign prostatic hyperplasia. Urology. 2000 Apr;
55(4): 533-9.
6. Wilt T, Ishani A, Mac Donald R, Rutks I, Stark G: Pygeum africanum for benign prostatic
hyperplasia. Cochrane Database Syst Rev. 2002; (1): CD001044
7. Ishani A, MacDonald R, Nelson D, Rutks I, Wilt TJ: Pygeum africanum for the treatment
of patients with benign prostatic hyperplasia: a systematic review and quantitative
meta-analysis.Am J Med. 2000 Dec 1; 109(8): 654-64.
8. Debruyne F, Koch G, Boyle P, Da Silva FC, Gillenwater JG, Hamdy FC, Perrin P, Teillac
P, Vela-Navarrete R, Raynaud JP: Comparison of a phytotherapeutic agent (Permixon)
with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a
1-year randomized international study.Eur Urol. 2002 May; 41(5): 497-506.
9. Willetts KE, Clements MS, Champion S, Ehsman S, Eden JA. Serenoa repens extract for
benign prostate hyperplasia: a randomized controlled trial. BJU Int. 2003 Aug; 92(3):
267-70.
10. Glemain P, Coulange C, Billebaud T, Gattegno B, Muszynski R, Loeb G; Groupe de
l’essai OCOS. [Tamsulosin with or without Serenoa repens in benign prostatic
hyperplasia: the OCOS trial]. Prog Urol. 2002 Jun; 12(3): 395-403.
11. MacDonal R, Ishani A, Rutks I, Wilt TJ: A systematic review of cernilton for the treatment
of benign prostatic hyperplasia. BJU Int. 2000 May; 85(7): 836-41.
12. Preuss HG, Marcusen C, Regan J, Klimberg IW, Welebir TA, Jones WA.Randomized trial
of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E)
on symptoms of benign prostatic hyperplasia (BPH). Int Urol Nephrol. 2001; 33(2):
217-25.
13. Lowe FC, Fagelman E Phytotherapy in the treatment of benign prostatic hyperplasia.
Curr Opin Urol. 2002 Jan; 12(1): 15-8.
14. Friederich M, Theurer C, Schiebel-Schlosser G. Prosta Fink Forte capsules in the treatment
of benign prostatic hyperplasia. Multicentric surveillance study in 2245 patients. Forsch
Komplementarmed Klass Naturheilkd. 2000 Aug; 7(4): 200-4.
15. Berges RR, Windeler J, Trampish H, Senge TH, and the beta-sitosterol study group:
Randomized, placebo-controlled, double-blind clinical trial of beta-sitosterol in patient
with benign prostatic hyperplasia. Lancet 1995; 345: 1529-32.
16. Klippel KF, Hilti DM, Schipp B for the german BPH-Phytotherapy Study Group: A
multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol)
for the treatment of benign prostatic hyperplasia. Br J Urol 1997; 80: 427-32.
171